VanEck Biotech ETF (BBH)
NASDAQ: BBH
· Real-Time Price · USD
171.84
6.16 (3.72%)
At close: Oct 01, 2025, 1:49 PM
3.72% (1D)
| Bid | 171.83 |
| Market Cap | 362.69M |
| AUM | 342.31M |
| NAV | 163.28 |
| EPS (ttm) | 7.12 |
| PE Ratio (ttm) | 24.15 |
| Shares Out | 2.11M |
| Inception Date | Dec 19, 2011 |
| Ask | 172.03 |
| Volume | 5,112 |
| Open | 169.08 |
| Previous Close | 165.68 |
| Day's Range | 169.08 - 172.60 |
| 52-Week Range | 135.34 - 178.95 |
| Holdings | 26 |
| Expense Ratio | 0.35% |
About BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol BBH
Inception Date Dec 19, 2011
Provider Vaneck
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 67.46% of assets
| Name | Symbol | Weight |
|---|---|---|
| Gilead Sciences, Inc... | GILD | 12.67% |
| Amgen Inc. | AMGN | 12.64% |
| Vertex Pharmaceutica... | VRTX | 9.69% |
| Regeneron Pharmaceut... | REGN | 5.09% |
| Alnylam Pharmaceutic... | ALNY | 4.82% |
| Argenx Se | ARGX | 4.76% |
| Beone Medicines Ltd. | ONC | 4.64% |
| Iqvia Holdings Inc. | IQV | 4.47% |
| Insmed Incorporated | INSM | 4.41% |
| Natera, Inc. | NTRA | 4.27% |
Dividends Dividend Yield 0.79%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 23, 2024 | $1.2517 | Dec 24, 2024 |
| Dec 18, 2023 | $0.7127 | Dec 22, 2023 |
| Dec 19, 2022 | $0.7488 | Dec 23, 2022 |
| Dec 20, 2021 | $0.3972 | Dec 27, 2021 |
| Dec 21, 2020 | $0.6079 | Dec 28, 2020 |
4 weeks ago · seekingalpha.com
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBHBiotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated. BBH offers a concentrated portfolio of leading innovators wit...
